allicin has been researched along with Alloxan Diabetes in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Song, Q; Wang, X; Yan, Y; Zhang, X | 1 |
| Gao, W; Li, CL; Li, WJ; Liu, DS; Liu, XH; Ma, CM; Ning, LN; Qiao, Y; Sun, YS | 1 |
| Cetinkalp, S; Demir, D; Toygar, I; Tureyen, A | 1 |
| Bai, B; Cao, YG; Huang, W; Li, L; Liu, Y; Qi, HP; Sun, HL; Wang, Y | 1 |
| Huang, H; Jiang, Y; Mao, G; Ruan, Y; Wu, T; Yuan, F; Zheng, H | 1 |
| Cao, Y; Huang, W; Ji, Z; Li, L; Liu, Y; Qi, H; Sun, H; Wang, Y; Wu, M | 1 |
| Adnan, A; Alashkham, F; Osman, M; Salmah Bakar, N | 1 |
| Augusti, KT | 1 |
8 other study(ies) available for allicin and Alloxan Diabetes
| Article | Year |
|---|---|
Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products.
Topics: Animals; Diabetes Mellitus, Experimental; Glycation End Products, Advanced; Oxidative Stress; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products | 2022 |
Allicin alleviates inflammation of diabetic macroangiopathy via the Nrf2 and NF-kB pathway.
Topics: Animals; Apoptosis; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disulfides; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Streptozocin; Sulfinic Acids | 2020 |
Effect of allicin on wound healing: an experimental diabetes model.
Topics: Animals; Bandages; Diabetes Mellitus, Experimental; Diabetic Foot; Disease Models, Animal; Disulfides; Female; Male; Random Allocation; Rats; Rats, Wistar; Streptozocin; Sulfinic Acids; Wound Healing | 2020 |
Antiarrhythmic effects and ionic mechanisms of allicin on myocardial injury of diabetic rats induced by streptozotocin.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Barium Compounds; Blood Glucose; Calcium Channels, L-Type; Chlorides; Diabetes Mellitus, Experimental; Disulfides; Heart; Male; Myocytes, Cardiac; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; RNA, Messenger; Sulfinic Acids | 2013 |
Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
Topics: Albumins; Albuminuria; Allium; Animals; Blood Glucose; Blood Urea Nitrogen; Collagen Type I; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disulfides; Hyperglycemia; Kidney; MAP Kinase Signaling System; Phosphorylation; Phytotherapy; Plant Extracts; Plant Roots; Rats, Sprague-Dawley; Streptozocin; Sulfinic Acids; Transforming Growth Factor beta1; Triglycerides | 2017 |
Allicin protects against myocardial apoptosis and fibrosis in streptozotocin-induced diabetic rats.
Topics: Animals; Apoptosis; Blood Glucose; Calcium; Cardiotonic Agents; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Disulfides; Drug Evaluation, Preclinical; fas Receptor; Heart; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Streptozocin; Sulfinic Acids; Transforming Growth Factor beta | 2012 |
Allicin has significant effect on autoimmune anti-islet cell antibodies in type 1 diabetic rats.
Topics: Animals; Autoantibodies; Autoantigens; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disulfides; Enzyme-Linked Immunosorbent Assay; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Rats; Rats, Sprague-Dawley; Sulfinic Acids | 2012 |
Studies on the effect of allicin (diallyl disulphide-oxide) on alloxan diabetes.
Topics: Allyl Compounds; Animals; Blood Glucose; Caseins; Diabetes Mellitus, Experimental; Disulfides; Glycosuria; Hypoglycemic Agents; Nitrogen; Rabbits; Sulfinic Acids; Tolbutamide | 1975 |